Dr. Michael Rodriguez
Medical Oncologist
Community-based medical oncologist treating a diverse patient population with various cancer types. While CLL represents a small portion of his practice, he has extensive experience with BTK inhibitors and manages several CLL patients. Practices in a community setting with limited access to clinical trials. Focuses on practical treatment approaches and patient convenience.
Treatment Preferences
Most experienced with ibrutinib and familiar with its side effect profile. Prefers continuous oral therapies for patient convenience. Less familiar with newer treatment options but interested in learning. Values treatments that are easy to monitor in a community setting. May refer complex cases to academic centers.